TABLE 1.
Baseline characteristics by PRE-(PRE), peri- (PERI), and post- (POST) menopause following randomization into 12 wk of habitual physical activity (CON, n = 25) or supervised low-impact resistance exercise (EXC, n = 45) intervention groups.
| CON | EXC | ANOVA | |||||||
|---|---|---|---|---|---|---|---|---|---|
| PRE | PERI | POST | PRE | PERI | POST | Menopause | Intervention | Intervention–menopause | |
| n (%) | 8 (32) | 6 (24) | 11 (44) | 19 (42) | 9 (20) | 17 (37) | |||
| Age (yr) | 46.9 ± 2.1a | 52.8 ± 1.6b | 57.4 ± 1.7a,b | 46.6 ± 3.5a | 52.4 ± 1.8b | 56.8 ± 2.8a,b | <0.001 | 0.843 | 0.939 |
| Height (m) | 1.6 ± 0.1 | 1.6 ± 0.1 | 1.6 ± 0.1 | 1.7 ± 0.1 | 1.6 ± 0.1 | 1.7 ± 0.1 | 0.741 | 0.781 | 0.603 |
| Body mass (kg) | 64.9 ± 10.1 | 67.5 ± 6.1 | 65.5 ± 8.0 | 66.2 ± 7.5 | 68.9 ± 6.6 | 65.1 ± 8.3 | 0.951 | 0.875 | 0.752 |
| BMI (kg·m−2) | 24.1 ± 3.1 | 24.8 ± 1.9 | 24.6 ± 2.6 | 24.0 ± 1.8 | 25.5 ± 2.4 | 23.7 ± 2.1 | 0.529 | 0.997 | 0.913 |
| Physical activity (MET·wk) | 2663 ± 776 | 2689 ± 1175 | 3117 ± 468 | 2958 ± 1430 | 2812 ± 408 | 2901 ± 759 | 0.691 | 0.801 | 0.682 |
| Dietary protein intake (g·d−1) | 73.2 ± 21.5 | 65 ± 19.5 | 61.9 ± 11.9 | 73.0 ± 18.6 | 71.8 ± 13.2 | 71.2 ± 17.1 | 0.404 | 0.233 | 0.620 |
| FSH (IU·L−1)c | 5.1 ± 1.7a | 59.7 ± 2 25.4b | 78.6 ± 20.1b | 6.9 ± 6.0a | 49.7 ± 35.3b | 88.7 ± 31.8a,b | <0.001 | 0.686 | 0.432 |
| 17β-Estradiol (pmol·L−1)c | 408.1 ± 475.5 | 153.0 ± 151.2 | 22.5 ± 10.0b | 451.2 ± 448.2 | 482.2 ± 584.6 | 96.3 ± 217.3a,b | <0.001 | 0.203 | 0.427 |
| Progesterone (nmol·L−1)c | 19.2 ± 21.8 | 1.2 ± 1.5b | 0.3 ± 0.1b | 15.0 ± 21.6 | 1.7 ± 2.3 | 0.5 ± 0.4b | <0.001 | 0.730 | 0.268 |
Values with units represent mean ± SD; significance set at P < 0.05.
a Significant difference from PERI.
b Significant difference from PRE.
c Raw values presented.